To include your compound in the COVID-19 Resource Center, submit it here.

FDA, NORD to include patient input in Orphan discussions

FDA unveiled several initiatives to help drive development of rare disease treatments, including a deal with the National Organization for Rare Disorders to integrate patient experience into regulatory

Read the full 287 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE